Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Todd Zankel currently holds 651,866 shares of Raptor Pharmaceutical Corp (RPTP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Todd Zankel has been a net seller of RPTP stock. They have purchased $0 and sold $398.0K worth of shares.
Todd Zankel's most recent insider trade was on Sep 4, 2012, when they sold 842 shares at $5.00 per share.
Todd Zankel serves as Executive at Raptor Pharmaceutical Corp (RPTP). They have executed 36 insider transactions totaling $398.0K over their tenure at the company.
Todd Zankel holds the position of Executive at Raptor Pharmaceutical Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Todd Zankel has shown a selling trading pattern, with $0 in total purchases and $398.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Todd Zankel was on May 1, 2012, when they sold $102.3K worth of RPTP shares. This transaction involved 17,484 shares at $5.85 per share.
Todd Zankel currently owns 651,866 shares of Raptor Pharmaceutical Corp (RPTP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Todd Zankel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Todd Zankel has 36 Form 4 filings on record as an insider at Raptor Pharmaceutical Corp.
Set alerts for Todd Zankel and 40,000+ other insiders.